Alliancebernstein L.P. Krystal Biotech, Inc. Transaction History

Alliancebernstein L.P.

$287 Billion
Q3 2024

A detailed history of Alliancebernstein L.P. transactions in Krystal Biotech, Inc. stock. As of the latest transaction made, Alliancebernstein L.P. holds 29,720 shares of KRYS stock, worth $4.71 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

29,720

Previous 29,720 -0.0%

Holding current value

$4.71 Million

Previous $5.46 Million 0.97%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$153.12 - $183.64 $912,595 - $1.09 Million	5,960 Added 25.08%	29,720 $5.46 Million
Q1 2024 May 14, 2024	SELL	$108.01 - $179.35 $231,141 - $383,809	-2,140 Reduced 8.26%	23,760 $4.23 Million
Q3 2023 Nov 14, 2023	SELL	$108.51 - $130.22 $21,702 - $26,044	-200 Reduced 0.77%	25,900 $3 Million
Q4 2022 Feb 14, 2023	BUY	$63.14 - $79.9 $37,884 - $47,940	600 Added 2.35%	26,100 $2.07 Million
Q2 2022 Aug 15, 2022	BUY	$48.93 - $73.47 $102,753 - $154,287	2,100 Added 8.97%	25,500 $1.67 Million
Q1 2022 May 13, 2022	BUY	$51.99 - $72.11 $140,373 - $194,697	2,700 Added 13.04%	23,400 $1.56 Million
Q2 2021 Jul 30, 2021	BUY	$62.14 - $81.82 $441,194 - $580,922	7,100 Added 52.21%	20,700 $1.41 Million
Q1 2021 May 06, 2021	BUY	$59.42 - $85.46 $17,826 - $25,637	300 Added 2.26%	13,600 $1.05 Million
Q3 2020 Nov 12, 2020	SELL	$37.76 - $48.49 $26,432 - $33,943	-700 Reduced 5.0%	13,300 $573,000
Q2 2020 Aug 13, 2020	BUY	$37.03 - $60.0 $96,278 - $156,000	2,600 Added 22.81%	14,000 $580,000
Q1 2020 May 14, 2020	SELL	$35.02 - $65.64 $21,012 - $39,384	-600 Reduced 5.0%	11,400 $493,000
Q4 2019 Feb 18, 2020	BUY	$33.17 - $65.23 $89,559 - $176,121	2,700 Added 29.03%	12,000 $665,000
Q3 2019 Nov 14, 2019	BUY	$34.72 - $51.3 $41,664 - $61,560	1,200 Added 14.81%	9,300 $323,000
Q2 2019 Aug 14, 2019	BUY	$27.2 - $41.2 $220,320 - $333,720	8,100 New	8,100 $326,000

Others Institutions Holding KRYS

# of Institutions

309

Shares Held

24.3M

Call Options Held

483K

Put Options Held

364K

View Full List

About Krystal Biotech, Inc.

Ticker KRYS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,664,300
Market Cap $4.06B
Description
Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...

More about KRYS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Account

Alliancebernstein L.P. Krystal Biotech, Inc. Transaction History